We’re all intrigued by rankings and flock to them for good reason. When it comes to ranking companies by market capitalization, you can assume that the named companies are leaders in their own right. They never stop innovating. They never stop changing. They never stop investing in their business. These are companies that we can admire and learn from.
Genetic Engineering & Biotechnology News shared its ranking of the top 25 biotechnology companies in 2017. Companies were ranked by their market capitalization.
If there’s one thing to take away from this list, it’s that the life sciences industry is truly global. A number of the “top” companies are based outside the United States and Europe, which illustrates the growing amount of research and progress that is taking place in Asia.
#25. Perrig – $11.90 billion
#24. Sinopharm Group – $12.36 billion
#23. Genmab – $12.52 billion
#22. UCB – $13.97 billion
#21. BioMarin Pharmaceutical – $14.51 billion
#20. Shanghai Fosun Pharmaceutical Group -$14.95 billion
#19. Kangmei Pharmaceutical $15.63 billion
#18. Yunnan Baiyao Group – $16.11 billion
#17. Sun Pharmaceutical Industries – $19.59 billion
#16. Mylan – $20.86 billion
#15. Samsung Biologics – $21.78 billion
#14. Incyte – $24.28 billion
#13. Jiangsu Hengrui Medicine – $27.90 billion
#12. Alexion Pharmaceuticals – $28.65 billion
#11. Vertex Pharmaceuticals – $37.03 billion
#10. Shire – $42.15 billion
#9. Regeneron Pharmaceuticals – $44.83 billion
#8. CSL – $48.30 billion
#7. Teva – $48.75 billion
#6. Allergan – $59.19 billion
#5. Biogen – $66.14 billion
#4. Celgene – $77.35 billion
#3. Novo Nordisk – $96.18 billion
#2. Gilead Sciences – $102.96 billion
#1. Amgen – $129.09 billion
